514
Participants
Start Date
July 31, 2007
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Rotigotine
2 mg/24 hr (one 10 cm\^2) transdermal patch applied daily for titration and maintenance period - 16 weeks
Rotigotine
4 mg/24 hr (one 20 cm\^2) transdermal patch applied daily for titration and maintenance period - 16 weeks
Placebo
Placebo transdermal patch applied daily
Rotigotine
6 mg/24 hr (one 10 cm\^2 \& one 20 cm\^2) transdermal patches applied daily for titration and maintenance period - 16 weeks
Rotigotine
8 mg/24 hr (two 10 cm\^2 \& one 20 cm\^2) transdermal patches applied daily for titration and maintenance period - 16 weeks
Birmingham
Tuscaloosa
Gilbert
Peoria
Phoenix
Scottsdale
Little Rock
Fountain Valley
Fresno
Irvine
La Jolla
Loma Linda
Oxnard
Aurora
New Haven
Boca Raton
Bradenton
Jacksonville
Miami
Naples
Ocala
Ormond Beach
Pompano Beach
St. Petersburg
Sunrise
Atlanta
Decatur
Macon
Suwanee
Chicago
Anderson
Des Moines
Kansas City
Louisville
Southfield
Golden Valley
St Louis
Missoula
Omaha
Las Vegas
Commack
New York
Rochester
Raleigh
Salisbury
Columbus
Toledo
Greensburg
Souderton
Upland
Memphis
Lubbock
San Antonio
Midvale
South Ogden
Alexandria
Richmond
Roanoke
Virginia Beach
Kirkland
Spokane
Milwaukee
Santiago
Hyderbad
Bangalore
Mangalore
Mysore
Calicut
Thiruvananthapuram
Indore
Mumbai
Pune
Chennai
Aguascalientes
Monterrey
San Isidro
Santiago de Surco
Lead Sponsor
UCB Pharma
INDUSTRY